EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunotherapy for HPV negative head and neck squamous cell carcinoma

Binyumeng Jiang, Ahmed Elkashif, Jonathan A Coulter, Nicholas J Dunne, Helen O McCarthy

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024

DOI: 10.1016/j.bbcan.2024.189138 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024. Verfasst von Binyumeng Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Immunotherapy, Head and Neck Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck cancer (HNSCC) is the 8th most common cancer in the UK, with incidence increasing due to lifestyle factors such as tobacco and alcohol abuse. HNSCC is an immune-suppressive disease characterised by impaired cytokine secretion and dysregulation of immune infiltrate. As such, immunotherapy is a potential treatment option, with therapeutic cancer vaccination demonstrating the greatest potential. The success of cancer vaccination is dependent on informed antigen selection: an ideal antigen must be either tumour-specific or tumour-associated, as well as highly immunogenic. Stratification of the patient population for antigen expression and validated biomarkers are also vital. This review focuses on the latest developments in immunotherapy, specifically the development of therapeutic vaccines, and highlights successes, potential drawbacks and areas for future development. Immunotherapy approaches considered for HNSCC include monoclonal antibodies (mAb), Oncolytic viral (OV) therapies, Immune Checkpoint Inhibitors (ICIs) and cancer vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckImmunotherapyHead and Neck NeoplasmsCancer VaccinesHumansImmune Checkpoint InhibitorsOncolytic VirotherapyAntibodies, Monoclonal

Stichwörter der Autor:innen

Dendritic cellsHNSCCImmunotherapyT-cellsVaccinesmRNA

Substanzen

Cancer VaccinesImmune Checkpoint InhibitorsAntibodies, Monoclonal

Autor:innen und Institutionen

  • School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.
  • School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin 9, Ireland.
  • School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK. Electronic address: h.mccarthy@qub.ac.uk.

Zitieren

APA

Jiang, B., Elkashif, A., Coulter, J. A., Dunne, N. J., & McCarthy, H. O. (2024). Immunotherapy for HPV negative head and neck squamous cell carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2024.189138

Vancouver

Jiang B, Elkashif A, Coulter JA, Dunne NJ, McCarthy HO. Immunotherapy for HPV negative head and neck squamous cell carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024. doi:10.1016/j.bbcan.2024.189138

BibTeX
@article{Jiang2024,
  author = {Jiang, Binyumeng and Elkashif, Ahmed and Coulter, Jonathan A and Dunne, Nicholas J and McCarthy, Helen O},
  title = {Immunotherapy for HPV negative head and neck squamous cell carcinoma},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2024},
  doi = {10.1016/j.bbcan.2024.189138}
}
Kostenlos starten →